Skip to content

Larimar Therapeutics, Inc.

LRMR· NasdaqCore metricsCIK 1374690

Pharmaceutical preparations552 peers

Last sale
Nov 12, 2026 · -1.28%
Market cap
$281.99M
104.63M shares
Filings
709
$0.00
Q1 2020
-$31.14M
Q3 2026N/M FY25 yoy
-$32.46M
Q3 2026N/M FY25 yoy
-$119.99M
Q3 2026derivedN/M FY25 yoy
-$0.61
Q3 2025N/M FY24 yoy
$76.99M
Q3 2026+157.1% FY25 yoy
$281.99M
—
—
2.8×
-40.18%
—

FY2025 figures · derived

Price

$2.7025.76%$0.94past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$0.00FY 2019
$0.000FY 2012FY 2013FY 2014FY 2015FY 2016FY 2017FY 2018FY 2019
PeriodEndedValueKindSource trail
FY 20192019-12-31$0reported
FY 20182018-12-31$0reported
FY 20172017-12-31$0reported
FY 20162016-12-31$0reported
FY 20152015-12-31$0reported
FY 20142014-12-31$0reported
FY 20132013-12-31$0reported
FY 20122012-12-31$0reported

Pharmaceutical preparations

Larimar Therapeutics, Inc. is the 228th largest of the 553 covered companies the SEC files under this code, by market cap. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Larimar Therapeutics, Inc. · CIK 1374690 · Engraved from SEC EDGAR